Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback